These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

583 related items for PubMed ID: 31953613

  • 1. Long non-coding RNA MALAT1 facilitates the tumorigenesis, invasion and glycolysis of multiple myeloma via miR-1271-5p/SOX13 axis.
    Liu N, Feng S, Li H, Chen X, Bai S, Liu Y.
    J Cancer Res Clin Oncol; 2020 Feb; 146(2):367-379. PubMed ID: 31953613
    [Abstract] [Full Text] [Related]

  • 2. LncRNA MALAT1 accelerates non-small cell lung cancer progression via regulating miR-185-5p/MDM4 axis.
    Wang D, Zhang S, Zhao M, Chen F.
    Cancer Med; 2020 Dec; 9(23):9138-9149. PubMed ID: 33146951
    [Abstract] [Full Text] [Related]

  • 3. Long non-coding RNA MALAT1 regulates proliferation, apoptosis, migration and invasion via miR-374b-5p/SRSF7 axis in non-small cell lung cancer.
    Song J, Su ZZ, Shen QM.
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1853-1862. PubMed ID: 32141554
    [Abstract] [Full Text] [Related]

  • 4. LncRNA MALAT1/miR-181a-5p affects the proliferation and adhesion of myeloma cells via regulation of Hippo-YAP signaling pathway.
    Sun Y, Jiang T, Jia Y, Zou J, Wang X, Gu W.
    Cell Cycle; 2019 Oct; 18(19):2509-2523. PubMed ID: 31397203
    [Abstract] [Full Text] [Related]

  • 5. Long Non-coding RNA MALAT1 Alleviates the Elevated Intraocular Pressure (Eiop)-induced Glaucoma Progression via Sponging miR-149-5p.
    Wang L, Gong J, Wang J, Dan J, Wang P.
    Curr Eye Res; 2021 Jun; 46(6):903-911. PubMed ID: 33108931
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. CircRNA CDR1as knockdown inhibits progression of non-small-cell lung cancer by regulating miR-219a-5p/SOX5 axis.
    Li Y, Zhang J, Pan S, Zhou J, Diao X, Liu S.
    Thorac Cancer; 2020 Mar; 11(3):537-548. PubMed ID: 31917898
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. THAP9-AS1 promotes nasopharyngeal carcinoma progression through targeted regulation of the miR-185-5p/SOX13 axis.
    Mo J, Gong Z, Liu H, Zhou L, Zhao Y.
    Physiol Int; 2024 Mar 21; 111(1):19-34. PubMed ID: 38270621
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Downregulation of long non-coding RNA UCA1 represses tumorigenesis and metastasis of osteosarcoma via miR-513b-5p/E2F5 axis.
    Zhang Z, Wu X, Han Q, Huang Z.
    Anticancer Drugs; 2021 Jun 01; 32(6):602-613. PubMed ID: 33595944
    [Abstract] [Full Text] [Related]

  • 12. LncRNA MALAT1 mediates doxorubicin resistance of hepatocellular carcinoma by regulating miR-3129-5p/Nova1 axis.
    Cao Y, Zhang F, Wang H, Bi C, Cui J, Liu F, Pan H.
    Mol Cell Biochem; 2021 Jan 01; 476(1):279-292. PubMed ID: 32965597
    [Abstract] [Full Text] [Related]

  • 13. MALAT1 promotes osteosarcoma development by regulation of HMGB1 via miR-142-3p and miR-129-5p.
    Liu K, Huang J, Ni J, Song D, Ding M, Wang J, Huang X, Li W.
    Cell Cycle; 2017 Mar 19; 16(6):578-587. PubMed ID: 28346809
    [Abstract] [Full Text] [Related]

  • 14. MALAT1/miR-124/Capn4 axis regulates proliferation, invasion and EMT in nasopharyngeal carcinoma cells.
    Shi B, Wang Y, Yin F.
    Cancer Biol Ther; 2017 Oct 03; 18(10):792-800. PubMed ID: 28857668
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Long Non-Coding RNA Metastasis Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Promotes Hypertension by Modulating the Hsa-miR-124-3p/Nuclear Receptor Subfamily 3, Group C, Member 2 (NR3C2) and Hsa-miR-135a-5p/NR3C2 Axis.
    Luo L, Wang Y, Hu P, Wu J.
    Med Sci Monit; 2020 Mar 29; 26():e920478. PubMed ID: 32222724
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.